Efficacy of Prophylactic Itraconazole in High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation
Status:
Completed
Trial end date:
2008-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate whether the prophylactic use of itraconazole is a
better option than empirical use of itraconazole in the management (prevention and treatment)
of fungal infection associated with high-dose chemotherapy and autologous hematopoietic stem
cell transplantation in children with high-risk solid tumor.